.svg)
Correction to: EGFR Targeted Paclitaxel and Piperine Co-loaded Liposomes for the Treatment of Triple Negative Breast Cancer (AAPS PharmSciTech, (2020), 21, 5, (151), 10.1208/s12249-020-01671-7)
| dc.contributor.author | Burande A.S.; Viswanadh M.K.; Jha A.; Mehata A.K.; Shaik A.; Agrawal N.; Poddar S.; Mahto S.K.; Muthu M.S. | |
| dc.date.accessioned | 2025-05-23T11:30:33Z | |
| dc.description.abstract | As the authors were working on similar projects on liposomes at the same time, the 3D figures of Fig. 3 bi and Fig. 3 bii were inadvertently misplaced. © 2020, American Association of Pharmaceutical Scientists. | |
| dc.identifier.doi | https://doi.org/10.1208/s12249-020-01755-4 | |
| dc.identifier.uri | http://172.23.0.11:4000/handle/123456789/12311 | |
| dc.relation.ispartofseries | AAPS PharmSciTech | |
| dc.title | Correction to: EGFR Targeted Paclitaxel and Piperine Co-loaded Liposomes for the Treatment of Triple Negative Breast Cancer (AAPS PharmSciTech, (2020), 21, 5, (151), 10.1208/s12249-020-01671-7) |